NKTR
$39.22+7.04%
Nektar TherapeuticsStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.004% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
How Nektar Therapeutics uses its cash
Period
FY2018
Where does Nektar Therapeutics's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.
Nektar Therapeutics · FY2018 · year ended 2018-12-31
Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.